TRUE Private Wealth Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

TRUE Private Wealth Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,233	Closed	-$292K	–	811
2019 Q1	$292K	Sell	3,233 -170	-5%	-$14.5K	0.06%	157
2018 Q4	$244K	Sell	3,403 -48,916	-93%	-$3.94M	0.04%	202
2018 Q3	$5.02M	Sell	52,319 -1,117	-2%	-$108K	0.71%	29
2018 Q2	$5.09M	Buy	53,436 +196	+0.4%	+$18K	0.8%	25
2018 Q1	$4.67M	Buy	53,240 +3,131	+6%	+$286K	0.8%	24
2017 Q4	$4.25M	Sell	50,109 -635	-1%	-$53.2K	0.74%	29
2017 Q3	$4.39M	Buy	+50,744	New	+$4.07M	0.99%	20

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

TRUE Private Wealth Advisors's XBI Position: Q2 2019 in Review

TRUE Private Wealth Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2019, closing a stake of 3,233 shares — an estimated $292K sold.

TRUE Private Wealth Advisors first reported a position in XBI in Q3 2017 and held it in 7 quarters. The position peaked at $5.09M in Q2 2018. 424 funds tracked by Wall St. Rank hold XBI as of Q2 2019.

TRUE Private Wealth Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2019 after selling out during the quarter.
TRUE Private Wealth Advisors sold 3,233 State Street SPDR S&P Biotech ETF shares in Q2 2019, an estimated $292K.
TRUE Private Wealth Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q3 2017 and held it in 7 quarters.
TRUE Private Wealth Advisors's State Street SPDR S&P Biotech ETF position peaked at $5.09M in Q2 2018.
424 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2019.

Based on TRUE Private Wealth Advisors's 13F filing for Q2 2019, filed 1 Aug 2019.